Tech Company Financing Transactions
RDD Pharma Funding Round
Capital Point, OrbiMed and Pharmascience participated in a $9.5 million Series B capital raise for RDD Pharma. The round was announced on 11/17/2017.
Transaction Overview
Company Name
Announced On
11/17/2017
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Series B
Investors
Proceeds Purpose
Proceeds will be used to advance programs globally in anal fissure, fecal incontinence, radiation colitis/proctitis and pruritus ani.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Columbus Cir. 15th Floor
New York, NY 10019
USA
New York, NY 10019
USA
Phone
Website
Email Address
Overview
RDD Pharma is a privately held specialty pharma company focused on fast-track development and commercialization of innovative therapeutics for anorectal diseases and lower-gastrointestinal tract disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Laufer
Chief Medical Officer
Nir Barak
Vice President
Howard Rice
VP - Operations
Robert Shleypak
VP - Regulatory Affairs
Robert Niecestro
Browse more venture capital transactions:
Prev: 11/17/2017: Modulated Imaging venture capital transaction
Next: 11/17/2017: Gainfully venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs